EMA recommends COVID-19 Vaccine Janssen for authorization in the EU

The European Medicines Agency has announced, that their human medicines committee (CHMP) concluded by consensus that the data on the Covid-19 vaccine Janssen were robust and met the criteria for efficacy, safety and quality.

"With this latest positive opinion, authorities across the European Union will have another option to combat the pandemic and protect the lives and health of their citizens," said Emer Cooke, EMA's Executive Director, adding, "this is the first vaccine which can be used as a single dose". These measures will allow regulators to swiftly assess data emerging from a range of different sources and take any necessary regulatory action to protect public health.